$1.3999
0.0499[3.70%]
At close: Apr 18
$1.3999
0[0.00%]
After Hours: 7:50PM EDT
Atossa Therapeutics
(NASDAQ:ATOS)Atossa Therapeutics Stock (NASDAQ:ATOS), Quotes and News Summary
Atossa Therapeutics Stock (NASDAQ: ATOS) stock price, news, charts, stock research, profile.
| Open | $1.310 |
| Close | $1.420 |
| Volume / Avg. | 2.324M / 1.545M |
| Day Range | 1.240 - 1.480 |
| 52 Wk Range | 0.590 - 2.310 |
| Market Cap | $175.413M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 8.43% |
| Days to Cover | 3.42 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Atossa Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovat...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Atossa Therapeutics (ATOS) stock?
You can purchase shares of Atossa Therapeutics (NASDAQ: ATOS) through any online brokerage.
Who are Atossa Therapeutics's (ATOS) competitors?
Other companies in Atossa Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), bluebird bio (NASDAQ:BLUE), GlycoMimetics (NASDAQ:GLYC) and Adicet Bio (NASDAQ:ACET).
What is the target price for Atossa Therapeutics (ATOS) stock?
The latest price target for Atossa Therapeutics (NASDAQ: ATOS) was reported by HC Wainwright & Co. on Tuesday, April 16, 2024. The analyst firm set a price target for 4.00 expecting ATOS to rise to within 12 months (a possible 185.73% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Atossa Therapeutics (ATOS)?
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $1.3999 last updated April 18, 2024 at 7:50 PM EDT.
Does Atossa Therapeutics (ATOS) pay a dividend?
There are no upcoming dividends for Atossa Therapeutics.
When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?
Atossa Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
Is Atossa Therapeutics (ATOS) going to split?
There is no upcoming split for Atossa Therapeutics.
What sector and industry does Atossa Therapeutics (ATOS) operate in?
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.